Walker Luke Nathaniel

Director at Zentalis Pharmaceuticals, Inc. · on record since May 29, 2024
Director at Context Therapeutics Inc. · on record since Sep 5, 2024
SVP, Clinical Development at CASCADE CORP · on record since Mar 20, 2017
Chief Medical Officer at Harpoon Therapeutics, Inc. · on record since Oct 4, 2022

Insider trading activity of Walker Luke Nathaniel

Figures computed from official regulatory filings — methodology.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Company	Filed	Type	Qty	Price	Value · USD	Src
Context Therapeutics Inc.	Jun 26, 2026	AwardD	45,000	0.00 USD	—	SEC
Zentalis Pharmaceuticals, Inc.	Jun 18, 2026	Award	57,100	0.00 USD	—	SEC
Zentalis Pharmaceuticals, Inc.	Jun 18, 2025	Award	57,603	0.00 USD	$0	SEC
Context Therapeutics Inc.	Jun 12, 2025	AwardD	123,500	0.00 USD	$0	SEC
Zentalis Pharmaceuticals, Inc.	Feb 4, 2025	Buy	14,200	1.76 USD	$25K	SEC
Context Therapeutics Inc.	Sep 5, 2024	AwardD	19,315	0.00 USD	$0	SEC
Zentalis Pharmaceuticals, Inc.	May 29, 2024	Award	72,481	0.00 USD	$0	SEC
Harpoon Therapeutics, Inc.	Mar 11, 2024	OtherD	-10,000	—	—	SEC
Harpoon Therapeutics, Inc.	Mar 11, 2024	Other	-135,000	—	—	SEC
Harpoon Therapeutics, Inc.	Mar 11, 2024	OtherD	-30,500	—	—	SEC
Harpoon Therapeutics, Inc.	Jan 9, 2024	Award	115,000	0.00 USD	$0	SEC
Harpoon Therapeutics, Inc.	Nov 28, 2023	Award	20,000	0.00 USD	$0	SEC
Harpoon Therapeutics, Inc.	Jan 26, 2023	AwardD	100,000	0.00 USD	$0	SEC
Harpoon Therapeutics, Inc.	Oct 4, 2022	AwardD	305,000	0.00 USD	$0	SEC
CASCADE CORP	Mar 13, 2018	OtherD	-8,334	—	—	SEC
CASCADE CORP	Mar 13, 2018	OtherD	-35,100	—	—	SEC
CASCADE CORP	Mar 13, 2018	OtherD	-50,000	—	—	SEC
CASCADE CORP	Mar 13, 2018	OtherD	-20,834	—	—	SEC
CASCADE CORP	Mar 13, 2018	OtherD	-1,250	—	—	SEC
CASCADE CORP	Mar 13, 2018	OtherD	-12,000	—	—	SEC
CASCADE CORP	Mar 13, 2018	OtherD	-2,500	—	—	SEC
CASCADE CORP	Mar 13, 2018	OtherD	-7,800	—	—	SEC
CASCADE CORP	Mar 13, 2018	OtherD	-2,500	—	—	SEC
CASCADE CORP	Mar 13, 2018	Other	-10,315	—	—	SEC
CASCADE CORP	Mar 13, 2018	OtherD	-1,250	—	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Context Therapeutics Inc.	Jun 26, 2026	AwardD	45,000	0.00 USD	—	SEC
Zentalis Pharmaceuticals, Inc.	Jun 18, 2026	Award	57,100	0.00 USD	—	SEC
Zentalis Pharmaceuticals, Inc.	Jun 18, 2025	Award	57,603	0.00 USD	$0	SEC
Context Therapeutics Inc.	Jun 12, 2025	AwardD	123,500	0.00 USD	$0	SEC
Zentalis Pharmaceuticals, Inc.	Feb 4, 2025	Buy	14,200	1.76 USD	$25K	SEC
Context Therapeutics Inc.	Sep 5, 2024	AwardD	19,315	0.00 USD	$0	SEC
Zentalis Pharmaceuticals, Inc.	May 29, 2024	Award	72,481	0.00 USD	$0	SEC
Harpoon Therapeutics, Inc.	Mar 11, 2024	OtherD	-10,000	—	—	SEC
Harpoon Therapeutics, Inc.	Mar 11, 2024	Other	-135,000	—	—	SEC
Harpoon Therapeutics, Inc.	Mar 11, 2024	OtherD	-30,500	—	—	SEC
Harpoon Therapeutics, Inc.	Jan 9, 2024	Award	115,000	0.00 USD	$0	SEC
Harpoon Therapeutics, Inc.	Nov 28, 2023	Award	20,000	0.00 USD	$0	SEC
Harpoon Therapeutics, Inc.	Jan 26, 2023	AwardD	100,000	0.00 USD	$0	SEC
Harpoon Therapeutics, Inc.	Oct 4, 2022	AwardD	305,000	0.00 USD	$0	SEC
CASCADE CORP	Mar 13, 2018	OtherD	-8,334	—	—	SEC
CASCADE CORP	Mar 13, 2018	OtherD	-35,100	—	—	SEC
CASCADE CORP	Mar 13, 2018	OtherD	-50,000	—	—	SEC
CASCADE CORP	Mar 13, 2018	OtherD	-20,834	—	—	SEC
CASCADE CORP	Mar 13, 2018	OtherD	-1,250	—	—	SEC
CASCADE CORP	Mar 13, 2018	OtherD	-12,000	—	—	SEC
CASCADE CORP	Mar 13, 2018	OtherD	-2,500	—	—	SEC
CASCADE CORP	Mar 13, 2018	OtherD	-7,800	—	—	SEC
CASCADE CORP	Mar 13, 2018	OtherD	-2,500	—	—	SEC
CASCADE CORP	Mar 13, 2018	Other	-10,315	—	—	SEC
CASCADE CORP	Mar 13, 2018	OtherD	-1,250	—	—	SEC